These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32037692)

  • 61. Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
    Rodriguez J; Pugh WC; Romaguera JE; Luthra R; Hagemeister FB; McLaughlin P; Rodriguez MA; Swan F; Cabanillas F
    Ann Oncol; 1994 Nov; 5(9):847-9. PubMed ID: 7848887
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Distinguishing Classical Hodgkin Lymphoma, Gray Zone Lymphoma, and Large B-cell Lymphoma: A Proposed Scoring System.
    O'Malley DP; Fedoriw Y; Weiss LM
    Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):535-40. PubMed ID: 26447896
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Eight-year experience in treating aggressive mediastinal large B-cell lymphomas].
    Mangasarova IaK; Magomedova AU; Kravchenko SK; Shmakov RG; Bariakh EA; Vorob'ev VI; Mar'in DS; Skidan NI; Gemdzhian ÉG; Misiurin AV; Kremenetskaia AM; Vorob'ev AI
    Ter Arkh; 2013; 85(7):50-6. PubMed ID: 24137947
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Mediastinal large-cell lymphoma of B-cell (thymic?) type. An anatomo-clinical entity in development].
    Sanchez Fayos J; Roman A; Nevado MI
    An Med Interna; 1996 Jan; 13(1):37-9. PubMed ID: 8679823
    [No Abstract]   [Full Text] [Related]  

  • 65. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
    Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group.
    Attarbaschi A; Dworzak M; Steiner M; Urban C; Fink FM; Reiter A; Gadner H; Mann G
    Pediatr Blood Cancer; 2005 Jan; 44(1):70-6. PubMed ID: 15368550
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma.
    Salama ME; Rajan Mariappan M; Inamdar K; Tripp SR; Perkins SL
    Int J Surg Pathol; 2010 Apr; 18(2):121-8. PubMed ID: 19223373
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma.
    Yang SH; Hsiao LT; Chiou TJ; Yang CF; Yu YB; Liu CY; Gau JP; Liu JH; Chen PM; Tzeng CH
    J Chin Med Assoc; 2015 Jul; 78(7):400-7. PubMed ID: 25801492
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases].
    Tchen N; Eghbali H; Soubeyran P; Trojani M; Richaud P; Bonnel C; Quénel-Tueux N; Hoerni B
    Bull Cancer; 1997 Jul; 84(7):704-8. PubMed ID: 9339196
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: role of rituximab, high-dose therapy, and allogeneic stem cell transplantation.
    Nath SV; Seymour JF
    Leuk Lymphoma; 2005 Jul; 46(7):1075-9. PubMed ID: 16019561
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma.
    Calvo KR; Traverse-Glehen A; Pittaluga S; Jaffe ES
    Adv Anat Pathol; 2004 Sep; 11(5):227-38. PubMed ID: 15322489
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Primary large cell lymphoma of the mediastinum.
    Aisenberg AC
    Semin Oncol; 1999 Jun; 26(3):251-8. PubMed ID: 10375082
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mediastinal large-cell lymphoma with sclerosis (MLCLS).
    Rohatiner AZ; Whelan JS; Ganjoo RK; Norton AJ; Wilson A; Lister TA
    Br J Cancer; 1994 Mar; 69(3):601-4. PubMed ID: 8123496
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Management of Primary Mediastinal B-Cell Lymphoma and Gray Zone Lymphoma.
    Dunleavy K
    Oncology (Williston Park); 2017 Jun; 31(6):499-501. PubMed ID: 28620906
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and feasibility of autologous stem cell transplantation in patients with diffuse large B‑cell lymphoma with secondary central nervous system involvement.
    Lee MY; Kim HS; Lee JY; Lim SH; Kang ES; Ko YH; Kim SJ; Kim WS
    Int J Hematol; 2015 Dec; 102(6):678-88. PubMed ID: 26493833
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High-dose chemotherapy followed by autologous stem cell transplantation for patients with refractory/relapsed classical Hodgkin lymphoma: a single center experience from China.
    Xie Y; Wang X; Leng X; Zheng W; Ping L; Zhang C; Liu W; Deng L; Wu M; Song Y; Zhu J
    Ann Hematol; 2020 Mar; 99(3):549-555. PubMed ID: 31980860
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.
    Giulino-Roth L; Ricafort R; Kernan NA; Small TN; Trippett TM; Steinherz PG; Prockop SE; Scaradavou A; Chiu M; O'Reilly RJ; Boulad F
    Pediatr Blood Cancer; 2013 Dec; 60(12):2018-24. PubMed ID: 24038967
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
    Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
    Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Autologous peripheral blood stem cell transplantation in the treatment of patients with primary large mediastinal B-cell lymphoma].
    He XH; Shi YK; Han XH; Zhou AP; Zhou SY; Liu P; Yang JL; Feng FY
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):592-5. PubMed ID: 14690571
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphoma.
    Malenda A; Kołkowska-Leśniak A; Puła B; Długosz-Danecka M; Chełstowska M; Końska A; Giza A; Lech-Marańda E; Jurczak W; Warzocha K
    Eur J Haematol; 2020 Jan; 104(1):59-66. PubMed ID: 31606909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.